Award
National Institute of Allergy and Infectious Diseases 1R21AI193666-01A1
Role of SLC46A3 in the pathogenesis of inflammatory bowel disease
Recipient
UNIV OF MASSACHUSETTS MED SCH WORCESTER
Award Amount
$251,250.00
Ceiling
$251,250.00
Awarded
April 22, 2026
Identifier
1R21AI193666-01A1
NIH awarded a research grant to study the role of the SLC46A3 transporter in inflammatory bowel disease, focusing on gut microbiota and NOD2 signaling, led by Ravi Bharadwaj at UMass Medical School.
Description
The project focuses on investigating the role of the SLC46A3 transporter in inflammatory bowel disease (IBD). It involves research on gut microbiota, NOD2 signaling, and IBD pathology. The project is funded by NIH grant PA-25-304 and is led by Principal Investigator Ravi Bharadwaj, an Assistant Professor at the University of Massachusetts Medical School Worcester. The project duration is from April 1, 2026, to March 31, 2028.